eClinical Tech News

BioNTech raised its 2025 revenue guidance to €2.6–2.8 billion and tightened spending plans after reporting third-quarter revenues of €1.52...

Nanobiotix has secured up to $71 million in non-dilutive financing from Healthcare Royalty, anchored to future economics from its...

DXS International posted audited results for the year ended 30 April 2025, reporting a 5% revenue rise to £3.47...

Plus Therapeutics introduced its CNSide cerebrospinal fluid diagnostics platform into the U.S. market, secured a first national coverage agreement...

Ardelyx posted third-quarter 2025 revenue of $110.3 million, anchored by a sharp acceleration in IBSRELA, which delivered $78.2 million,...

Amneal Pharmaceuticals posted third-quarter 2025 revenue of $785 million, up 12% year over year, and nudged its full-year outlook...

NovaBridge’s ophthalmology subsidiary, Visara, has assigned its exclusive license for VIS-101 to Everest Medicines for development, manufacturing, and commercialization...

BridgeBio reported third-quarter revenue of $120.7 million, fueled by $108.1 million in U.S. net product sales of Attruby (acoramidis)...

Roche has secured control of 89bio through a completed tender offer at 14.50 dollars per share in cash plus...

BridgeBio reported third-quarter revenue of $120.7 million, anchored by $108.1 million in U.S. net product sales from Attruby (acoramidis)...